当前位置:首页 - 行情中心 - 精华制药(002349) - 财务分析 - 现金流量表

精华制药

(002349)

  

流通市值:56.99亿  总市值:58.17亿
流通股本:8.14亿   总股本:8.31亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,060,239,258.06705,610,414.4340,014,082.741,471,942,868
  收到的税费返还283,791.12119,21326,943.37144,166.78
  收到其他与经营活动有关的现金17,287,528.59,823,076.856,140,050.1931,085,328.43
  经营活动现金流入小计1,077,810,577.68715,552,704.25346,181,076.31,503,172,363.21
  购买商品、接受劳务支付的现金383,055,483.84242,785,113.29120,634,463.88480,174,906.93
  支付给职工以及为职工支付的现金260,430,904.94188,598,809.99103,755,059.9331,662,625.6
  支付的各项税费126,171,176.9786,041,289.6937,869,939.62162,275,740.95
  支付其他与经营活动有关的现金134,071,043.4886,752,726.5947,466,604.33188,192,839.7
  经营活动现金流出小计903,728,609.23604,177,939.56309,726,067.731,162,306,113.18
  经营活动产生的现金流量净额174,081,968.45111,374,764.6936,455,008.57340,866,250.03
二、投资活动产生的现金流量:
  收回投资收到的现金1,086,234,560760,234,560328,250,0001,274,195,725.42
  取得投资收益收到的现金7,845,999.326,624,965.481,850,192.365,819,164.5
  处置固定资产、无形资产和其他长期资产收回的现金净额16,00016,000-47,200
  收到的其他与投资活动有关的现金30,144,833.3330,144,833.3310,144,833.3310,618,402.78
  投资活动现金流入小计1,124,241,392.65797,020,358.81340,245,025.691,290,680,492.7
  购建固定资产、无形资产和其他长期资产支付的现金23,744,322.7414,958,202.447,024,469.3220,323,490.93
  投资支付的现金1,045,000,000627,000,000289,000,0001,598,950,000
  支付其他与投资活动有关的现金264,043,277.78154,043,277.7884,043,277.78141,000,000
  投资活动现金流出小计1,332,787,600.52796,001,480.22380,067,747.11,760,273,490.93
  投资活动产生的现金流量净额-208,546,207.871,018,878.59-39,822,721.41-469,592,998.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,996,377.785,203,172-56,708,040
  取得借款收到的现金15,000,00013,000,0003,000,000-
  收到其他与筹资活动有关的现金2,440,186.94525,186.8154,7805,439,526.47
  筹资活动现金流入小计22,436,564.7218,728,358.83,154,78062,147,566.47
  偿还债务支付的现金5,200,000200,000200,00010,000,000
  分配股利、利润或偿付利息支付的现金97,805,623.597,735,667.9512,75084,990,973.01
  其中:子公司支付给少数股东的股利、利润---19,747,160
  支付其他与筹资活动有关的现金552,499.41417,399.41188,818869,253.69
  筹资活动现金流出小计103,558,122.9198,353,067.36401,56895,860,226.7
  筹资活动产生的现金流量净额-81,121,558.19-79,624,708.562,753,212-33,712,660.23
四、汇率变动对现金及现金等价物的影响-5,444,909.83-3,717,225.62-1,597,926.44-2,272,865.34
五、现金及现金等价物净增加额-121,030,707.4429,051,709.1-2,212,427.28-164,712,273.77
  加:期初现金及现金等价物余额848,808,462.7848,808,462.7848,808,462.71,013,520,736.47
  期末现金及现金等价物余额727,777,755.26877,860,171.8846,596,035.42848,808,462.7
补充资料:
  净利润-165,246,280.98-261,835,558.5
  资产减值准备-5,849,248.98-11,206,135.61
  固定资产和投资性房地产折旧-36,810,566.46-77,485,379.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-36,810,566.46-77,485,379.56
  无形资产摊销-1,040,860.05-2,113,806
  处置固定资产、无形资产和其他长期资产的损失--7,108.88-5,092.86
  固定资产报废损失-187,757.62-1,140,894.18
  公允价值变动损失--2,186,541.89--4,173,858.83
  财务费用--7,833,011.14--7,435,991.06
  投资损失--1,701,868.1--3,572,027.3
  递延所得税--555,784.24-1,333,582.11
  其中:递延所得税资产减少--792,940.53--998,246.67
    递延所得税负债增加-237,156.29-2,331,828.78
  存货的减少-7,317,121.09--17,727,553.88
  经营性应收项目的减少--51,855,159.05--13,202,694.66
  经营性应付项目的增加--52,957,271.34-13,187,260.07
  其他-11,679,286.38-17,685,033.02
  融资租入固定资产---2,361,642.28
  现金的期末余额-877,860,171.8-848,808,462.7
  减:现金的期初余额-848,808,462.7-1,013,520,736.47
  现金及现金等价物的净增加额-29,051,709.1--164,712,273.77
公告日期2026-10-272026-08-272026-04-302026-04-23
审计意见(境内)标准无保留意见
TOP↑